Centre of Excellence
Neurotrauma
The provision of neurointensive care in Uppsala has a distinguished reputation internationally, with respect to both treatment results and research.
The most important role of neurointensive care is to prevent deterioration of injuries to the brain after damage to the head or after a brain haemorrhage. Swedish researchers were quick to see the implications of optimising intensive care so as to minimise the negative impact of neurotrauma. Progress in this area has been significant in Uppsala, and we have a long tradition of close cooperation between clinical activities, clinical research and basic research.
The Neurointensive Care department at Uppsala University Hospital is one of the most modern in the world; the patients are intensively monitored, using advanced methods which, in many cases, were developed here. These methods steer the treatment of the patients, and patient care follows a standardised protocol. Because of this, we have a closely controlled situation in health care, which leads to very good treatment results. Today, the chances that patients will survive are good, and treatment is thus mainly about preparing the patients for the best life possible.
Inflammation
Inflammatory processes form the basis of nearly three-quarters of all the illnesses that humans are susceptible to. The area is enormous and includes, among others, cardiovascular diseases, gastrointestinal diseases, skin diseases, asthma and allergies, infectious diseases and joint diseases. In Uppsala, we have an unusually broad, deep pool of resources offering finely honed skills in the diagnosis and treatment of inflammatory diseases.
Our researchers are constantly developing new diagnostic methods and treatments that in many respects lead the world. The close cooperation among doctors from many different areas of the hospital gives us unique opportunities to offer help to patients with very difficult-to-diagnose and difficult-to-treat inflammatory diseases.
Endocrine Tumors
Every year, hundreds of patients from around the world come to Uppsala University Hospital to receive care and treatment at the Endocrine Oncology Clinic. The skills and experience at the clinic are internationally regarded as first class in terms of treatment of patients with hormone-producing tumours and research into the general area. The hospital is currently concentrating on expanding this area by setting up a Centre of Excellence for endocrine tumours. Hormone-producing tumours are extremely rare, constituting only just over one percent of all malignant tumours.
Uppsala University Hospital is the only hospital in Europe, and one of only a few hospitals in the world, which has a special clinic specifically focused on this diagnostic group.
Because of this specialization, a large number of patients have come here, from both the rest of Sweden and abroad. This has meant that we have obtained unique clinical experience, which has been crucial for the research and development of new therapies. Over the 30 years that this clinical research has been carried out, the clinic has made great progress and has gradually developed new methods for diagnosis and treatment. The clinic works closely with several other activities at the hospital; for example, endocrine surgery, pathology, clinical chemistry, radiology, nuclear medicine and the PET centre.